Home HealthTopics Health Centers Reference Library Research
Join us on Facebook Join us on Facebook Share on Facebook


Atrovent Debate



Can you explain to me the debate of using Atrovent for pulmonary diseases? I know it is a generally localized Muscarinic antagonist. Is the debate dealing with the decreased mucous secretion and dilated bronchioles causing more exposure to allergens?


I`m not aware of any debate. Atrovent is a bronchodilator with anticholinergic activity. Several studies have shown excellent action on patients with COPD where it is often considered first line therapy. For asthma it also a bronchodilator but is mainly used as adjunctive therapy.

For more information:

Go to the Asthma health topic, where you can:

Response by:

Mitchell C Rashkin, MD Mitchell C Rashkin, MD
Professor of Medicine
College of Medicine
University of Cincinnati